Logo image of NVST

ENVISTA HOLDINGS CORP (NVST) Stock Fundamental Analysis

NYSE:NVST - New York Stock Exchange, Inc. - US29415F1049 - Common Stock - Currency: USD

20.08  -0.12 (-0.59%)

Fundamental Rating

4

Overall NVST gets a fundamental rating of 4 out of 10. We evaluated NVST against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of NVST get a neutral evaluation. Nothing too spectacular is happening here. NVST scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

NVST had positive earnings in the past year.
NVST had a positive operating cash flow in the past year.
In multiple years NVST reported negative net income over the last 5 years.
Each year in the past 5 years NVST had a positive operating cash flow.
NVST Yearly Net Income VS EBIT VS OCF VS FCFNVST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

NVST has a Return On Assets of -20.57%. This is comparable to the rest of the industry: NVST outperforms 48.66% of its industry peers.
NVST has a Return On Equity (-37.03%) which is in line with its industry peers.
NVST has a Return On Invested Capital of 2.59%. This is in the better half of the industry: NVST outperforms 70.05% of its industry peers.
NVST had an Average Return On Invested Capital over the past 3 years of 4.17%. This is below the industry average of 7.89%.
Industry RankSector Rank
ROA -20.57%
ROE -37.03%
ROIC 2.59%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
NVST Yearly ROA, ROE, ROICNVST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Operating Margin of NVST (6.01%) is better than 72.73% of its industry peers.
NVST's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 54.77%, NVST perfoms like the industry average, outperforming 50.80% of the companies in the same industry.
In the last couple of years the Gross Margin of NVST has remained more or less at the same level.
Industry RankSector Rank
OM 6.01%
PM (TTM) N/A
GM 54.77%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
NVST Yearly Profit, Operating, Gross MarginsNVST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NVST is destroying value.
NVST has more shares outstanding than it did 1 year ago.
NVST has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NVST has a worse debt to assets ratio.
NVST Yearly Shares OutstandingNVST Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVST Yearly Total Debt VS Total AssetsNVST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

NVST has an Altman-Z score of 1.49. This is a bad value and indicates that NVST is not financially healthy and even has some risk of bankruptcy.
NVST has a Altman-Z score (1.49) which is in line with its industry peers.
The Debt to FCF ratio of NVST is 5.27, which is a neutral value as it means it would take NVST, 5.27 years of fcf income to pay off all of its debts.
NVST has a Debt to FCF ratio of 5.27. This is amongst the best in the industry. NVST outperforms 81.82% of its industry peers.
NVST has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
NVST has a Debt to Equity ratio (0.43) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.27
Altman-Z 1.49
ROIC/WACC0.36
WACC7.25%
NVST Yearly LT Debt VS Equity VS FCFNVST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

NVST has a Current Ratio of 2.12. This indicates that NVST is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.12, NVST is doing worse than 63.10% of the companies in the same industry.
NVST has a Quick Ratio of 1.82. This is a normal value and indicates that NVST is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.82, NVST perfoms like the industry average, outperforming 48.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.82
NVST Yearly Current Assets VS Current LiabilitesNVST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

4

3. Growth

3.1 Past

NVST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.65%.
Measured over the past years, NVST shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -28.29% on average per year.
NVST shows a decrease in Revenue. In the last year, the revenue decreased by -2.30%.
NVST shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.90% yearly.
EPS 1Y (TTM)-49.65%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%-7.69%
Revenue 1Y (TTM)-2.3%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%-1.07%

3.2 Future

The Earnings Per Share is expected to grow by 33.46% on average over the next years. This is a very strong growth
NVST is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y40.2%
EPS Next 2Y29.16%
EPS Next 3Y23.71%
EPS Next 5Y33.46%
Revenue Next Year1.68%
Revenue Next 2Y2.46%
Revenue Next 3Y2.61%
Revenue Next 5Y7.74%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVST Yearly Revenue VS EstimatesNVST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
NVST Yearly EPS VS EstimatesNVST Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.28, the valuation of NVST can be described as expensive.
NVST's Price/Earnings ratio is a bit cheaper when compared to the industry. NVST is cheaper than 76.47% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, NVST is valued at the same level.
With a Price/Forward Earnings ratio of 16.49, NVST is valued correctly.
Based on the Price/Forward Earnings ratio, NVST is valued cheaper than 81.82% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, NVST is valued rather cheaply.
Industry RankSector Rank
PE 28.28
Fwd PE 16.49
NVST Price Earnings VS Forward Price EarningsNVST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NVST indicates a rather cheap valuation: NVST is cheaper than 80.21% of the companies listed in the same industry.
NVST's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NVST is cheaper than 93.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.71
EV/EBITDA 13.96
NVST Per share dataNVST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

NVST's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NVST's earnings are expected to grow with 23.71% in the coming years.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y29.16%
EPS Next 3Y23.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NVST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVISTA HOLDINGS CORP

NYSE:NVST (7/14/2025, 2:40:00 PM)

20.08

-0.12 (-0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners117.29%
Inst Owner Change-0.02%
Ins Owners0.45%
Ins Owner Change10.08%
Market Cap3.40B
Analysts73
Price Target19.61 (-2.34%)
Short Float %6.03%
Short Ratio4.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.98%
Min EPS beat(2)7.34%
Max EPS beat(2)14.62%
EPS beat(4)3
Avg EPS beat(4)-2.03%
Min EPS beat(4)-59.95%
Max EPS beat(4)29.88%
EPS beat(8)4
Avg EPS beat(8)-6.11%
EPS beat(12)6
Avg EPS beat(12)-4.55%
EPS beat(16)10
Avg EPS beat(16)-1.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.58%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)-0.26%
Revenue beat(4)0
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)-0.18%
Revenue beat(8)0
Avg Revenue beat(8)-2.02%
Revenue beat(12)0
Avg Revenue beat(12)-2.08%
Revenue beat(16)1
Avg Revenue beat(16)-2.89%
PT rev (1m)0%
PT rev (3m)-10.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)0.31%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 28.28
Fwd PE 16.49
P/S 1.36
P/FCF 12.71
P/OCF 11.48
P/B 1.12
P/tB 41.25
EV/EBITDA 13.96
EPS(TTM)0.71
EY3.54%
EPS(NY)1.22
Fwd EY6.06%
FCF(TTM)1.58
FCFY7.87%
OCF(TTM)1.75
OCFY8.71%
SpS14.77
BVpS17.91
TBVpS0.49
PEG (NY)0.7
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.57%
ROE -37.03%
ROCE 3.27%
ROIC 2.59%
ROICexc 3.38%
ROICexgc 21.13%
OM 6.01%
PM (TTM) N/A
GM 54.77%
FCFM 10.7%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
ROICexc(3y)4.97%
ROICexc(5y)5.02%
ROICexgc(3y)81.26%
ROICexgc(5y)N/A
ROCE(3y)5.28%
ROCE(5y)5.25%
ROICexcg growth 3Y-55.07%
ROICexcg growth 5Y-3.56%
ROICexc growth 3Y-21.01%
ROICexc growth 5Y-0.5%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.27
Debt/EBITDA 4.81
Cap/Depr 24.14%
Cap/Sales 1.15%
Interest Coverage 2.93
Cash Conversion 110.1%
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.82
Altman-Z 1.49
F-Score4
WACC7.25%
ROIC/WACC0.36
Cap/Depr(3y)41.77%
Cap/Depr(5y)41.11%
Cap/Sales(3y)2.19%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.65%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%-7.69%
EPS Next Y40.2%
EPS Next 2Y29.16%
EPS Next 3Y23.71%
EPS Next 5Y33.46%
Revenue 1Y (TTM)-2.3%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%-1.07%
Revenue Next Year1.68%
Revenue Next 2Y2.46%
Revenue Next 3Y2.61%
Revenue Next 5Y7.74%
EBIT growth 1Y-50.44%
EBIT growth 3Y-26.9%
EBIT growth 5Y-8.72%
EBIT Next Year46.17%
EBIT Next 3Y19.09%
EBIT Next 5Y29.05%
FCF growth 1Y145.91%
FCF growth 3Y-0.46%
FCF growth 5Y-1.09%
OCF growth 1Y62.64%
OCF growth 3Y-2.37%
OCF growth 5Y-3.28%